Zhejiang Syncozymespharmaceutical Co., Ltd. The enzyme catalysis project passed the preliminary review of the key research and development plan of Zhejiang Province

Classification： Company News

Publication：2020-09-28 15:55

In August 2020, the "Bio-enzyme Library Development and Green Catalytic Synthesis Application" project of Zhejiang Syncozymespharmaceutical Co., Ltd. passed the preliminary review of the Zhejiang Provincial Key R&D Program of the Zhejiang Provincial Department of Science and Technology.

Zhejiang Syncozymes-Pharmaceutical Co., Ltd. is located in Binhai New Area, Shaoxing, Zhejiang, covering an area of 230 acres and strategically located in the middle section of the south bank of Hangzhou Bay, with Hangzhou in the west, Ningbo in the east, and Jiaxing in the north. It mainly produces KRED/ATA/IRED/NIT/NHT/ERED series of biological enzymes, coenzyme NMN/NAD/NADH/NADP series products and Ibrutinib and other APIs and preparations.

Previous: [Good news] Syncozymes's NMN products have passed the safety certification of SELF GRAS in the United States

Next: Syncozymes's NMN raw material passed the "Acute Oral Toxicity Test"

Leave a Message Online